Metraipolis › archive › dc_8dbaf17c39ee

Evaluating serum procollagen type III N-terminal peptide use as a liver fibrosis screening test in patients with psoriasis receiving methotrexate: a… — Europe PMC PMID:42813182

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42813182
DOI
10.1093/skinhd/vzag116
License (as archived)
solo-consultazione
Archived
2026-10-17T06:37:21.993Z
SHA-256 of the archived text
d5d95ff83b9a2149e5012cacc91fff6c5e55886d9f788a52a211f61f574af5dc
Stable URL of this page
https://metraipolis.com/documento/dc_8dbaf17c39ee

How to cite

Evaluating serum procollagen type III N-terminal peptide use as a liver fibrosis screening test in patients with psoriasis receiving methotrexate: a… — Europe PMC PMID:42813182 — Europe PMC (en), https://europepmc.org/article/MED/42813182 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8dbaf17c39ee (Metraipolis archive dc_8dbaf17c39ee, sha256 d5d95ff83b9a2149e5012cacc91fff6c5e55886d9f788a52a211f61f574af5dc)
BibTeX
@misc{dc8dbaf17c39ee,
  title = {Evaluating serum procollagen type III N-terminal peptide use as a liver fibrosis screening test in patients with psoriasis receiving methotrexate: a… — Europe PMC PMID:42813182},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42813182},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8dbaf17c39ee; sha256 d5d95ff83b9a2149e5012cacc91fff6c5e55886d9f788a52a211f61f574af5dc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42813182. Agents can read the archived copy with the MCP tool read_document.